Upgrade to SI Premium - Free Trial

Nkarta (NKTX)

2.92 +0.01 (0.34%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Nkarta to Participate in September Investor Conferences September 10, 2026 7:00 AM - StreetInsider Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026 September 8, 2026 7:00 AM - StreetInsider Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses August 14, 2026 8:10 AM - StreetInsider Nkarta Inc. (NKTX) PT Lowered to $14 at H.C. Wainwright August 11, 2026 6:51 AM - StreetInsider Nkarta, Inc. (NKTX) Misses Q2 EPS by 18c August 10, 2026 6:18 PM - StreetInsider Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights August 10, 2026 4:24 PM - Globe NewsWire Form 10-Q Nkarta, Inc. For: Jun 30 August 10, 2026 4:20 PM - SEC Filing Form 8-K Nkarta, Inc. For: Aug 10 August 10, 2026 4:13 PM - SEC Filing Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development July 23, 2026 1:30 AM - StreetInsider Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference June 26, 2026 8:45 AM - StreetInsider TD Cowen Starts Nkarta Inc. (NKTX) at Buy June 23, 2026 5:43 AM - StreetInsider Form 4 Nkarta, Inc. For: Jun 18 Filed by: HASTINGS PAUL J June 22, 2026 4:05 PM - SEC Filing Full Article List